A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Interleukin-27 Inhibits Herpes Simplex Virus Type 1 Infection by Activating STAT1 and 3, Interleukin-6, and Chemokines IP-10 and MIG




TekijätHeikkila O, Nygardas M, Paavilainen H, Ryodi E, Hukkanen V

KustantajaMARY ANN LIEBERT, INC

Julkaisuvuosi2016

JournalJournal of Interferon and Cytokine Research

Tietokannassa oleva lehden nimiJOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Lehden akronyymiJ INTERF CYTOK RES

Vuosikerta36

Numero11

Aloitussivu617

Lopetussivu629

Sivujen määrä13

ISSN1079-9907

DOIhttps://doi.org/10.1089/jir.2016.0015


Tiivistelmä
Interleukin-27 (IL-27) inhibits the replication of many viruses, but the mechanism differs according to virus and cell type. In this study, we observed that IL-27 expression was upregulated in herpes simplex virus type 1 (HSV-1)-infected SJL/J mice, which led us to further investigate the role of IL-27 in HSV-1 infection using epithelial, glioma, and immunological cells as cell models. We showed that in all studied cell lines, the IL-27 messenger RNA (mRNA) level was upregulated due to the HSV-1 infection. When the cells were primed with IL-27 before the virus infection, the virus release was prevented, indicating an antiviral role of IL-27 in HSV-1 infection. Furthermore, we observed that IL-27 secretion to the culture medium was reduced in infected epithelial and immunological cells, but not in glioma cells. Not surprisingly, HSV-1 induced type I, II, and III interferons regardless of cell line, but IL-27 itself caused varying interferon responses dependent on cell type. However, common to all cell types was the IL-27-stimulated secretion of IL-6 and chemokines IP-10 and MIG. In addition, IL-27 stimulation activated STAT1 and STAT3 in HeLa and T98G cells, suggesting that IL-27 engages the STAT1/3 pathway, which then leads to the upregulation of IL-6, IP-10, and MIG.



Last updated on 2024-26-11 at 16:17